Genomics of post-prandial lipidomic phenotypes in the Genetics of Lipid lowering Drugs and Diet Network (GOLDN) study.
about
Clinical applications of epigenetics in cardiovascular disease: the long road aheadHigher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36.Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events.An efficient analytic approach in genome-wide identification of methylation quantitative trait loci response to fenofibrate treatmentHomozygosity disequilibrium associated with treatment response and its methylation regulationDetecting responses to treatment with fenofibrate in pedigrees
P2860
Genomics of post-prandial lipidomic phenotypes in the Genetics of Lipid lowering Drugs and Diet Network (GOLDN) study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genomics of post-prandial lipi ...... nd Diet Network (GOLDN) study.
@ast
Genomics of post-prandial lipi ...... nd Diet Network (GOLDN) study.
@en
type
label
Genomics of post-prandial lipi ...... nd Diet Network (GOLDN) study.
@ast
Genomics of post-prandial lipi ...... nd Diet Network (GOLDN) study.
@en
prefLabel
Genomics of post-prandial lipi ...... nd Diet Network (GOLDN) study.
@ast
Genomics of post-prandial lipi ...... nd Diet Network (GOLDN) study.
@en
P2093
P2860
P50
P1433
P1476
Genomics of post-prandial lipi ...... nd Diet Network (GOLDN) study.
@en
P2093
Devin M Absher
Hemant K Tiwari
Stella Aslibekyan
Steve Watkins
P2860
P304
P356
10.1371/JOURNAL.PONE.0099509
P407
P577
2014-06-06T00:00:00Z